Storia in 3 fonti

Hanmi Pharm in spotlight as Korea's 1st obesity drug nears launch - The Korea Times

Hanmi Pharmaceutical is gaining attention as it prepares to launch Korea’s first glucagon-like peptide-1 (GLP-1)-based obesity drug, Eppe, while al...

Raccontata da

morningstar.com

koreaherald.com

koreatimes.co.kr

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

koreatimes.co.krStai leggendo1 g fa

Hanmi Pharm in spotlight as Korea's 1st obesity drug nears launch - The Korea Times

Hanmi Pharmaceutical is gaining attention as it prepares to launch Korea’s first glucagon-like peptide-1 (GLP-1)-based obesity drug, Eppe, while al...

originale

koreaherald.com3 g fa

Hanmi signs record $2.3b obesity drug deal with Genentech

Hanmi Pharmaceutical said Monday it has inked an exclusive licensing agreement with Genentech for its obesity drug candidate HM17321 in a deal that could be wor

Leggi questa versione → originale

Timeline cronologica

lunedì 24 agosto 2026·morningstar.com
Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
lunedì 24 agosto 2026·koreaherald.com
Hanmi signs record $2.3b obesity drug deal with Genentech
Hanmi Pharmaceutical said Monday it has inked an exclusive licensing agreement with Genentech for its obesity drug candidate HM17321 in a deal that could be wor

Hanmi Pharm in spotlight as Korea's 1st obesity drug nears launch - The Korea Times

Hanmi signs record $2.3b obesity drug deal with Genentech

Timeline cronologica

Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy

Hanmi signs record $2.3b obesity drug deal with Genentech

Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy

Hanmi Pharm signs $2.3 bil. licensing deal with Roche's Genentech for obesity drug candidate - The Korea Times

Hanmi Pharm in spotlight as Korea's 1st obesity drug nears launch - The Korea Times